摘要
微生物次级代谢产物结构新颖、活性多样,一直以来都是药物及其先导化合物的重要来源。但近年来在普通微生物纯培养中发现的新活性物质不断减少,重复发现逐渐增加;而微生物共培养因更加接近微生物生长的自然环境,在药物及其先导物挖掘方面发挥着越来越重要的作用。本文分析了近5年来利用真菌vs真菌、真菌vs细菌共培养挖掘新活性化合物的研究现状,以及研究中存在的问题。
Microbial secondary metabolites have been an important source of drugs and their leading compounds because of their novel chemical structures and various biological activities. However, in recent years, there is a high frequency of re-discovery and a low frequency of new discovery of active compounds from microbial pure culture. As microbial co-culture is closer to the natural environment of microbial growth, it plays an important role in new compound mining. Here, we review the progress of new compound mining through co-culture from fungi vs fungi and fungi vs bacteria, and the current problems of this field for future research is also mentioned.
出处
《微生物学通报》
CAS
CSCD
北大核心
2017年第10期2437-2442,共6页
Microbiology China
基金
重大新药创制-创新微生物药物候选物(No.2012ZX09301002-001-024-6)
中央级公益性科研院所基本科研业务专项基金项目(No.2016ZX350044
2016ZX350061)~~
关键词
共培养
真菌
次级代谢产物
Co-culture, Fungi, Secondary metabolite